Yıl: 2020 Cilt: 21 Sayı: 5 Sayfa Aralığı: 296 - 302 Metin Dili: İngilizce DOI: 10.5152/TurkThoracJ.2019.19011 İndeks Tarihi: 17-05-2021

Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy

Öz:
OBJECTIVES: The number of studies on the frequency of obstructive sleep apnea (OSA) in subjects with sarcoidosis is low. Therefore, we aimed to investigate the frequency and predictors of OSA in subjects with clinically stable stage I and II sarcoidosis who were not taking corticosteroid and/or immunosuppressive drugs. We also evaluated restless legs syndrome (RLS) and periodic leg movements in sleep (PLMS). MATERIALS AND METHODS: Subjects with clinically stable stage I and II sarcoidosis and not receiving corticosteroid and/or immunosuppressive therapy were included in the study. Upper airway examination, lung function tests (forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], diffusing capacity of the lungs for carbon monoxide [DLCO]), and polysomnography were performed on all subjects. In addition, subjects' Epworth Sleepiness Scale (ESS) scores and the Pittsburgh Sleep Quality Index (PSQI) were recorded.RESULTS: Of the total number of 46 sarcoidosis subjects (35 women, 11 men; age: 44.4±10.7 years; body mass index (BMI): 29.3±5 kg/m2), 28 (60.9%) were detected with OSA (67.8% mild OSA). The recorded ESS score of the subjects was low (2.6±3.2), whereas the sleep quality was poor in 36.9% of these subjects. Rapid eye movements (REM) related OSA was diagnosed in 14.2% of the OSA subjects. Age was the only factor related to OSA diagnosis in a logistic regression analysis (p=0.048). None of the subjects were diagnosed with RLS and PLMS.CONCLUSION: OSA is common in stage I and II sarcoidosis subjects who did not receive corticosteroid therapy. The frequency of OSA diagnosis increases as the age of the subjects increases. Therefore, sarcoidosis subjects should be evaluated for OSA throughout the follow-up
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders - Third Edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine, 2014.
  • 2. Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;15:263-76. [Crossref]
  • 3. Mermigkis C, Chapman J, Golish J, et al. Sleep-related breathing disorders in subjects with idiopathic pulmonary fibrosis. Lung 2007;185:173-8. [Crossref]
  • 4. Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009;136:772-8. [Crossref]
  • 5. Pihtili A, Bingol Z, Kiyan E, et al. Obstructive sleep apnea is common in subjects with interstitial lung disease. Sleep Breath 2013;17:1281-8. [Crossref]
  • 6. Lal C, Medarov BI, Judson MA. Interrelationship between sleepdisordered breathing and sarcoidosis. Chest 2015;148:1105-14. [Crossref]
  • 7. Turner GA, Lower EE, Corser BC, et al. Sleep apnea in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997;14:61-4.
  • 8. Chitra Lal, Heidi Grund, Charlie Strange. Sleep Disturbances in Sarcoidosis Subjects. Chest 2012;142:426. [Crossref]
  • 9. Bingol Z, Pihtili A, Gülbaran Z, Kiyan E. Relationship between parenchymal involvement and obstructive sleep apnea in subjects with sarcoidosis. Clin Respir J 2015;9:14-21. [Crossref]
  • 10. Verbraecken J, Hoitsma E, van der Grinten CP, et al. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004;2:137-46.
  • 11. Statement On Sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Associatıon of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
  • 12. American Thoracic Society Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36. [Crossref]
  • 13. Izci B, Ardic S, Firat H, et al. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath 2008;12:161-8. [Crossref]
  • 14. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research, Psychiatry Research 1989;28:193-213. [Crossref]
  • 15 Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine J Clin Sleep Med 2012;15;8:597-619. [Crossref]
  • 16. Acosta-Castro P, Hirotsu C, Marti-Soler H, et al. REM-associated sleep apnoea: prevalence and clinical significance in the HypnoLaus cohort. Eur Respir J. 2018; 16;52. pii: 1702484. [Crossref]
  • 17. Duce B, Kulkas A, Langton C, Töyräs J, Hukins C. The AASM 2012 recommended hypopnea criteria increase the incidence of obstructive sleep apnea but not the proportion of positional obstructive sleep apnea. Sleep Med. 2016;26:23-9. [Crossref]
  • 18. Cowan DC, Allardice G, MacFarlane D, et al. Predicting sleep disordered breathing in outpatients with suspected OSA. BMJ 2014;4:e004519. [Crossref]
  • 19. Patterson KC, Huang F, Oldham JM, et al. Excessive daytime sleepiness and obstructive sleep apnea in subjects with sarcoidosis. Chest 2013;143:1562-8. [Crossref]
  • 20. Hesselbacher S, Subramanian S, Allen J, et al. Body mass index, gender, and ethnic variations alter the clinical implications of the epworth sleepiness scale in patients with suspected obstructive sleep apnea. Open Respir Med J 2012;6:20-7. [Crossref]
  • 21. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleepdisordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310-8. [Crossref]
  • 22. Latka P, Huang H, Hohenforst-Schmidt W, et al. Sleep disorders and health-related quality of life in patients with interstitial lung disease. Sleep Breath. 2018;22:393-400. [Crossref]
  • 23. Basoglu OK, Tasbakan MS. Gender differences in clinical and polysomnographic features of obstructive sleep apnea: a clinical study of 2827 patients. Sleep Breath 2018;22:241-9. [Crossref]
  • 24. Ye L, Pien GW, Weaver TE. Gender differences in the clinical manifestation of obstructive sleep apnea. Sleep Med 2009;10:1075-84. [Crossref]
  • 25. Lal C1, Medarov BI2, Judson MA3. Interrelationship between sleep-disordered breathing and sarcoidosis. Chest 2015;148:1105-14. [Crossref]
  • 26. Mermigkis C, Stagaki E, Tryfon S, et al. How common is sleep disordered breathing in subjects with idiopatic pulmonary fibrosis? Sleep Breath 2010;14:387-90. [Crossref]
  • 27. Fuso L, Maiolo C, Tramaglino LM, et al. Orolaryngeal sarcoidosis presenting as obstructive sleep apnea. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 2001;18:85-90.
  • 28. Shah RN, Mills PR, George PJ, et al. Upper airways sarcoidosis presenting as obstructive sleep apnea. Thorax 1998;53:232-3. [CrossreF]
APA ERTAŞ DOĞAN M, Bingöl Z, Aydemir L, Okumus G, Orhan K, Atahan E, Ozkan G, Kıyan E (2020). Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. , 296 - 302. 10.5152/TurkThoracJ.2019.19011
Chicago ERTAŞ DOĞAN MEHTAP,Bingöl Züleyha,Aydemir Levent,Okumus Gulfer,Orhan Kadir Serkan,Atahan Ersan,Ozkan Gulcihan,Kıyan Esen Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. (2020): 296 - 302. 10.5152/TurkThoracJ.2019.19011
MLA ERTAŞ DOĞAN MEHTAP,Bingöl Züleyha,Aydemir Levent,Okumus Gulfer,Orhan Kadir Serkan,Atahan Ersan,Ozkan Gulcihan,Kıyan Esen Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. , 2020, ss.296 - 302. 10.5152/TurkThoracJ.2019.19011
AMA ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. . 2020; 296 - 302. 10.5152/TurkThoracJ.2019.19011
Vancouver ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. . 2020; 296 - 302. 10.5152/TurkThoracJ.2019.19011
IEEE ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E "Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy." , ss.296 - 302, 2020. 10.5152/TurkThoracJ.2019.19011
ISNAD ERTAŞ DOĞAN, MEHTAP vd. "Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy". (2020), 296-302. https://doi.org/10.5152/TurkThoracJ.2019.19011
APA ERTAŞ DOĞAN M, Bingöl Z, Aydemir L, Okumus G, Orhan K, Atahan E, Ozkan G, Kıyan E (2020). Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. Turkish Thoracic Journal, 21(5), 296 - 302. 10.5152/TurkThoracJ.2019.19011
Chicago ERTAŞ DOĞAN MEHTAP,Bingöl Züleyha,Aydemir Levent,Okumus Gulfer,Orhan Kadir Serkan,Atahan Ersan,Ozkan Gulcihan,Kıyan Esen Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. Turkish Thoracic Journal 21, no.5 (2020): 296 - 302. 10.5152/TurkThoracJ.2019.19011
MLA ERTAŞ DOĞAN MEHTAP,Bingöl Züleyha,Aydemir Levent,Okumus Gulfer,Orhan Kadir Serkan,Atahan Ersan,Ozkan Gulcihan,Kıyan Esen Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. Turkish Thoracic Journal, vol.21, no.5, 2020, ss.296 - 302. 10.5152/TurkThoracJ.2019.19011
AMA ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. Turkish Thoracic Journal. 2020; 21(5): 296 - 302. 10.5152/TurkThoracJ.2019.19011
Vancouver ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy. Turkish Thoracic Journal. 2020; 21(5): 296 - 302. 10.5152/TurkThoracJ.2019.19011
IEEE ERTAŞ DOĞAN M,Bingöl Z,Aydemir L,Okumus G,Orhan K,Atahan E,Ozkan G,Kıyan E "Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy." Turkish Thoracic Journal, 21, ss.296 - 302, 2020. 10.5152/TurkThoracJ.2019.19011
ISNAD ERTAŞ DOĞAN, MEHTAP vd. "Frequency of Obstructive Sleep Apnea in Stage I and IISarcoidosis Subjects Who Had No Corticosteroid Therapy". Turkish Thoracic Journal 21/5 (2020), 296-302. https://doi.org/10.5152/TurkThoracJ.2019.19011